Explore All Access
Check if your research matches the topics covered in Targeted Oncology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Targeted Oncology : Impact Factor & More
eISSN: 1776-260XpISSN: 1776-2596
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Targeted Oncology Key Metrics
CiteScore 
7.2
Impact Factor
5 - 10
SJR
Q2Oncology
SNIP
1.03
Topics Covered on Targeted Oncology
Epidermal growth factor receptor
Lung cancer
P53 expression
Progression-free survival
Breast cancer
Hepatocellular carcinoma
Crizotinib
Copanlisib
Overall survival
Pembrolizumab
Confidence interval
Adenocarcinoma
Objective response
Colorectal cancer
Mutation testing
Cerebrospinal fluid
Immunotherapy
Metastatic breast cancer
Melanoma
Erlotinib
Targeted Oncology Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2006 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Targeted Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Targeted Oncology
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
- 1 Nov 2023
- Targeted Oncology
Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
- 1 May 2023
- Targeted Oncology
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
- 21 Apr 2023
- Targeted Oncology
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
- 1 Mar 2023
- Targeted Oncology
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
- 1 Mar 2023
- Targeted Oncology
Acknowledgement to Referees
- 1 Nov 2022
- Targeted Oncology
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
- 1 Nov 2023
- Targeted Oncology
Trastuzumab Deruxtecan: A Review in Unresectable or Metastatic HER2-Positive Breast Cancer
- 1 May 2023
- Targeted Oncology
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer
- 21 Apr 2023
- Targeted Oncology
Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?
- 1 Mar 2023
- Targeted Oncology
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
- 1 Mar 2023
- Targeted Oncology
Acknowledgement to Referees
- 1 Nov 2022
- Targeted Oncology
Compare Similar Journals with Targeted Oncology
Select Journals to Compare with Targeted Oncology
Total journals - 9
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
BMC Cancer
Publisher: BMC
Oncotarget
Publisher: Impact Journals
0 Journals Selected to compare with
Targeted Oncology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Targeted Oncology
How long has Targeted Oncology been actively publishing? 
Targeted Oncology has been in operation since 2006 till date.
What is the publishing frequency of Targeted Oncology?
Targeted Oncology published with a Bi-monthly frequency.
How many articles did Targeted Oncology publish last year?
In 2023, Targeted Oncology publsihed 5 articles.
What is the eISSN & pISSN for Targeted Oncology?
For Targeted Oncology, eISSN is 1776-260X and pISSN is 1776-2596.
What is Citescore for Targeted Oncology?
Citescore for Targeted Oncology is 7.2.
What is SNIP score for Targeted Oncology?
SNIP score for Targeted Oncology is 1.03.
What is the SJR for Targeted Oncology?
SJR for Targeted Oncology is Q2.
Who is the publisher of Targeted Oncology?
SPRINGER is the publisher of Targeted Oncology.
